Trio-Tech International (TRT) gained by 3.40% today to $7.60 per share and is currently up by 13.77% since NIA's recent suggestion at $6.68 per share!
TRT has trailing twelve-month EBITDA of $7.575 million vs. AEHR Test Systems (AEHR) having trailing twelve-month EBITDA of $13.82 million.
TRT has trailing twelve-month operating cash flow of $8.11 million vs. AEHR having trailing twelve-month operating cash flow of $10.01 million.
TRT has an enterprise value of $18.60 million vs. AEHR's enterprise value now up to $1.26 BILLION!
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. This message is meant for informational and educational purposes only and does not provide investment advice.
Preparing Americans for Hyperinflation
